Search Results - Colleen Pineda
- Showing 1 - 1 results of 1
-
1
632 A phase 1/2 open label study of LabVax 3(22)-23 and adjuvant GM-CSF alone or in combination with pembrolizumab in subjects with labyrinthin-positive adenocarcinomas by Shuai Chen, Tianhong Li, Weijie Ma, Tingting Lu, Siqi Long, Kyra A Toomey, Michael Babich, Colleen Pineda, Laura Molnar, Leslie Garcia, Kit Tam, Rashmi Verma, Chihong Zhou, Nancy Ogilhara
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article